−0.015AUD
−11.31 MAUD
97.96 MAUD
266.68 M
About MEDADVISOR LIMITED
Sector
Industry
CEO
Richard Ratliff
Website
Headquarters
Camberwell
Founded
2010
ISIN
AU000000MDR6
FIGI
BBG001LRVJF2
MedAdvisor Ltd. engages in the provision of pharmacy-driven, innovative patient engagement solutions that simplify the patient medication journey to empower better health. It operates through the following segments: Australia and New Zealand Operations, the United States Operations, the United Kingdom Operations, Asia Operations, and Corporate. The company was founded by Joshua Swinnerton in 2010 and is headquartered in Camberwell, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MDR is 0.305 AUD — it has increased by 5.17% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange MEDADVISOR LIMITED stocks are traded under the ticker MDR.
MEDADVISOR LIMITED is going to release the next earnings report on Aug 29, 2024. Keep track of upcoming events with our Earnings Calendar.
MDR stock is 5.17% volatile and has beta coefficient of −0.17. Check out the list of the most volatile stocks — is MEDADVISOR LIMITED there?
MEDADVISOR LIMITED revenue for the last quarter amounts to 33.90 M AUD despite the estimated figure of 31.00 M AUD. In the next quarter revenue is expected to reach 54.20 M AUD.
Yes, you can track MEDADVISOR LIMITED financials in yearly and quarterly reports right on TradingView.
MDR stock has risen by 19.61% compared to the previous week, the month change is a 22.00% rise, over the last year MEDADVISOR LIMITED has showed a 29.79% increase.
MDR net income for the last quarter is 6.87 M AUD, while the quarter before that showed −15.90 M AUD of net income which accounts for 143.21% change. Track more MEDADVISOR LIMITED financial stats to get the full picture.
Today MEDADVISOR LIMITED has the market capitalization of 159.55 M, it has increased by 5.88% over the last week.
No, MDR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MDR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDADVISOR LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDADVISOR LIMITED technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDADVISOR LIMITED stock shows the buy signal. See more of MEDADVISOR LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MEDADVISOR LIMITED future price: according to them, MDR price has a max estimate of 0.44 AUD and a min estimate of 0.38 AUD. Read a more detailed MEDADVISOR LIMITED forecast: see what analysts think of MEDADVISOR LIMITED and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDADVISOR LIMITED EBITDA is −1.31 M AUD, and current EBITDA margin is −2.41%. See more stats in MEDADVISOR LIMITED financial statements.